Moderna’s efforts to develop a range of mRNA vaccines for influenza have been bolstered with funding of up to $750 million from investment firm Blackstone Life Sciences. The deal comes at a time ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ...

New additions are in bold.

Copyright © 2024 MarketWatch, Inc. All rights reserved.

Lennox International Inc through its subsidiaries is a provider of climate control solutions. It designs, manufactures and markets products for heating, ventilation, air conditioning and refrigeration ...